Recombinant Human RANKL/TNFSF11 Protein
PKSH031027
| Size: | Price: | $789 | |
| Qty: |
-
+
|
Lead Time: 7~10 days
Product Details
| Catalog number | PKSH031027 |
| Expression_host | HEK293 Cells |
| Sequence | Gly 64-Asp 245 |
| Bio_Activity | 1. Immobilized human TNFSF11 at 2 μg/ml (100 μl/well) can bind biotinylated human Osteoprotegerin hFc, The EC50 of human Osteoprotegerin hFc is 5-40 ng/ml. 2. The bioactivity of hRANKL was determined by measuring the ability of hRANKL to induce TRAP activity in Raw 264. 7 cells. The ED50 for this effect is typically 1.5-7.5 ng/mL. |
| Application | Functional ELISA |
| Accession | AAC51762.1 |
| Synonyms | CD254;ODF;OPGL;RANKL;TNFSF11;CD254;Osteoclast differentiation factor;Receptor activator of nuclear factor kappa-B ligand;tumor necrosis factor ligand superfamily member 11;hRANKL2;OPTB2;RANKL;sOdf |
| Tag | None |
| Purity | > 85 % as determined by reducing SDS-PAGE. |
| Endotoxin | < 1.0 EU per μg of the protein as determined by the LAL method. |
| Formulation | Lyophilized from sterile PBS, pH 7.4 Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Please refer to the specific buffer information in the printed manual. |
